Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial "NICHE"


Phase N/A Results N/A

Summary of Purpose

A pivotal, prospective, multi-center, randomized, controlled, double-blinded study combining active Nexstim NBS-guided 1Hz rTMS or sham-rTMS targeting the healthy hemisphere with standardized task oriented rehabilitation will be conducted in patients with post-stroke motor impairment. The therapy will be provided for 6 weeks and primary outcome assessed 6 months later.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 September 2017.

1 Apr 2014 14 Mar 2014 1 May 2016 1 May 2016 1 Sep 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment